• Revenue of cold & cough Philippines 2012-2025

In the Philippines, the cold & cough remedy segment within the OTC pharmaceutical market generated approximately 153 million U.S. dollars in revenue in 2020. This value will increase to an estimated 165 million USD by 2025, according to the Consumer Market Outlook.

Revenue of cold & cough remedies in the Philippines from 2012 to 2025 (in million U.S. dollars)

Characteristic	Revenue in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

More information

Supplementary notes

The Cold and Cough segment comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

All figures are estimates. Details on the methodology can be found at https://cdn.statcdn.com/static/img/outlook/CMO-Methodik_en.pdf.